1-(2,3-Dichlorophenyl)piperazine Hydrochloride CAS 119532-26-2 Aripiprazole Waena Ma'ema'e >99.0% (HPLC)

ʻO ka wehewehe pōkole:

Inoa: 1-(2,3-Dichlorophenyl)piperazine Hydrochloride

Nā huaʻōlelo like: 2,3-DCPP HCl

CAS: 119532-26-2

Maʻemaʻe: >99.0% (HPLC)

ʻAno: Pahu keʻokeʻo a i ʻole keʻokeʻo

Kūwaena o Aripiprazole (CAS: 129722-12-9)

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia 1-(2,3-Dichlorophenyl)piperazine Hydrochloride
Nā huaʻōlelo like 2,3-DCPP HCl;1-(2,3-Dichlorophenyl)piperazine HCl;Aripiprazole EP Ka haumia B;Aripiprazole pili pūhui C
Helu CAS 119532-26-2
Helu CAT RF-PI2268
Kūlana Kūʻai Ma ka waihona, ka mana hana 30 MT / mahina
ʻĀpana Molekala C10H12Cl2N2·HCl
Kaumaha Molecular 267.58
Lae hehee 245.0~247.0 ℃
Hoʻopaʻa a me ka ʻike Hygroscopic.Nā mahana wela
Solubility i ka wai Hiki i ka wai
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Pada keʻokeʻo a i ʻole keʻokeʻo
Maʻemaʻe / Kaʻina Hanana >99.0% (HPLC)
Nalo ma ka maloo <0.50%
Koena ma ka Ignition <0.10%
Hoʻokahi haumia <0.50%
Huina paumaele <1.00%
Nā Metala Kaumaha (e like me Pb) ≤20ppm
Infrared Spectrum Kūlike i ka hoʻolālā
Kūlana hoʻāʻo Kūlana ʻoihana
Hoʻohana Kūwaena o Aripiprazole (CAS: 129722-12-9)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:Hygroscopic.E mālama ʻia mai ka wai/makū a me nā mea hoʻoheheʻe.E hoʻopaʻa paʻa i ka pahu a waiho i loko o kahi kūlana anuanu, maloʻo a me ka makani maikaʻi.E kūʻai ma lalo o ke kinoea inert

Pono:

1

FAQ:

Noi:

ʻO 1-(2,3-Dichlorophenyl) piperazine Hydrochloride (CAS: 119532-26-2) kahi mea koʻikoʻi waena o Aripiprazole (CAS: 129722-12-9).ʻO Aripiprazole kahi ʻano hou o ka lipid soluble quinoline derivatives, ʻo kona ʻano hopena pharmacological ʻaʻole ia wale nō ka postsynaptic dopamine D 2 receptor antagonist, akā ʻo ka presynaptic dopamine D 2 receptor agonist, hiki iā ia ke hoʻoulu D 1, D 3, D 4 mea loaa ;loaʻa iā ia ka hopena ʻelua o ka hoʻāla ʻana a i ʻole ka mea hoʻokipa antagonistic ma 5-HT 1A receptor;loaʻa iā ia kahi hana antagonistic loa ma ka 5-HT 2A receptor.ʻOkoʻa kēia hiʻohiʻona mai ka hanauna mua, a me nā antipsychotics atypical e pili ana i ka lua o ka hanauna antipsychotic lāʻau, a no laila ua kapa ʻia ʻo dopamine system stabilizer a i ʻole ke kolu o ka hanauna antipsychotic.No ke kūʻai ʻia ʻana ma ka mākeke, hoʻohana nui ʻia i ka schizophrenia clinical, ka mālama ʻana i nā maʻi affective a me nā maʻi psychiatric ʻē aʻe.E like me ka palapala, aripiprazole loaʻa nā hopena koʻikoʻi i ka schizophrenia maikaʻi a me nā hōʻailona maikaʻi ʻole a me ka hopohopo, ke kaumaha, ka hana cognitive, ʻoiai ʻoi aku ka palekana.Ua hōʻike pū ʻia e hiki i ka lāʻau lapaʻau ke mālama i nā maʻi noʻonoʻo ʻē aʻe, e like me nā maʻi manic episodes, senile dementia e pili ana i nā maʻi noʻonoʻo, nā maʻi hopohopo, nā maʻi ʻano o nā keiki, ke kaumaha.I kēia mau lā, hoʻolaha ʻo Bristol-Myers Squibb a me Otsuka Pharmaceutical Company ua ʻae ka European Union iā Abilify (aripiprazole) i ka mālama ʻana i ka noi papa inoa schizophrenia.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou